CEVA, Inc. — FY2019 Form 10-K
Reporting period: Fiscal year ended December 31, 2019. The filing also includes unaudited quarterly results; FY2019 Q4 figures are identified below. Unless noted otherwise, financial amounts are U.S. dollars.
Business context
CEVA licenses wireless-connectivity and smart-sensing intellectual property, processors, platforms and software to semiconductor companies and OEMs. Revenue comes primarily from licensing and related services, plus royalties on licensees’ shipments. Key markets include mobile, consumer, automotive, industrial and IoT. In July 2019, CEVA acquired Hillcrest Labs’ sensor-fusion business and invested in Immervision for exclusive licensing rights to specified imaging technology.
Financial results and liquidity
| Metric | FY2019 | FY2018 | Change |
|---|---|---|---|
| Total revenue | $87.2 million | $77.9 million | +11.9% |
| Licensing and related revenue | $47.9 million | $40.4 million | +18.4% |
| Royalties | $39.3 million | $37.4 million | +4.9% |
| Gross profit / margin | $77.0 million / 88.4% | $69.9 million / 89.8% | Margin down 1.4 percentage points |
| Operating income (loss) | $(1.9) million | $(1.2) million | Loss widened |
| Net income | $28,000 | $574,000 | Near break-even |
| Cash provided by operations | $9.7 million | $8.6 million | Increased |
FY2019 operating expenses rose 11.0% to $79.0 million, including research and development expense of $52.8 million, up 10.7%. Income taxes were $1.3 million. The filing reports diluted EPS rounded to $0.00; the precise per-share amount is not clear from the displayed filing text.
For Q4 2019, revenue was $28.3 million versus $21.4 million in Q4 2018. Operating income was $3.5 million versus $2.2 million; net income was $3.1 million versus $2.3 million. Q4 licensing revenue was $14.8 million and royalties were $13.5 million.
At year-end, cash and cash equivalents were $22.8 million, short-term bank deposits $56.9 million, marketable securities $64.9 million and long-term bank deposits $5.4 million—approximately $150.0 million combined, compared with $167.7 million a year earlier. Working capital was $152.2 million. CEVA reported no long-term debt; operating lease liabilities totaled $10.7 million. Cash from operations was positive, while investing and financing activities used $2.4 million and $6.7 million, respectively.
Material changes and management commentary
- Licensing revenue reached a record, supported principally by vision and handset-baseband licensing. CEVA signed 52 license agreements, including 23 first-time customers; 2019 Q4 included 21 deals, 19 for non-cellular-handset-baseband applications.
- Royalty revenue returned to growth after declining in 2018. Non-handset-baseband royalty revenue rose 49% to approximately $13 million. Non-handset-baseband shipments reached a record 469 million units, up 25% year over year; total shipments exceeded 1 billion.
- Handset-baseband products remained a major exposure: they represented approximately 67% of royalty revenue in 2019, down from 77% in 2018. Spreadtrum contributed 15% of total revenue in both 2019 and 2018. The five largest royalty-paying customers represented 84% of royalty revenue.
- Connectivity products accounted for 81% of 2019 revenue and smart-sensing products 19%. Customers in Asia Pacific generated 56.3% of revenue, down from 67.0%; U.S. revenue rose to 19.0% from 10.7%.
- The Hillcrest acquisition and Immervision investment totaled approximately $21 million in cash consideration/investment. These transactions expanded sensor-fusion and imaging offerings and contributed to higher expenses and amortization.
- Management expects 2020 R&D expense to increase by approximately $7.9 million and cost of revenue by approximately $1.6 million, partly reflecting a full year of Hillcrest costs. It expects non-handset-baseband royalty revenue to reach $20 million in 2020.
- Management’s previously stated 2022 targets, measured against 2018, were licensing and related revenue growth of approximately 10%–20%, royalty revenue approximately twice as high, and non-GAAP net income approximately three times as high. These are forecasts, not reported results.
Risks, contingencies and unusual items
- Revenue and royalties depend on a limited number of customers and the success, shipment volumes and market acceptance of their products. Licensing revenue can vary significantly with deal timing; handset exposure, royalty-rate pressure and semiconductor cyclicality remain significant risks.
- Approximately 81% of revenue came from outside the United States. The filing identifies trade tensions, tariffs, foreign exchange movements, political instability and dependence on Asia-Pacific markets as risks. It also states that coronavirus-related impacts were uncertain and could affect customers, suppliers and logistics providers.
- IIA research grants were $5.8 million in 2019. Grant conditions and contingent repayments matter; royalties payable to the IIA were contingent on sales, with an aggregate contingent liability, including interest, of $25.8 million at year-end.
- Uncertain tax positions were $1.0 million at year-end; timing of any payment was not reasonably estimable. Management reported no litigation expected to have a material adverse effect.
- CEVA held $121.6 million of its year-end cash, deposits and marketable securities at foreign subsidiaries and intends to reinvest foreign earnings. Repatriation could entail taxes. Management said available resources and operating cash were expected to fund operations for at least 12 months.
- Other notable items: CEVA repurchased 355,180 shares for $9.1 million in 2019; the existing repurchase authorization was exhausted at year-end, and an additional 700,000 shares were authorized in February 2020. The auditor issued unqualified opinions on the financial statements and internal controls.
Important facts for investors to verify
- Whether non-handset royalty growth and the $20 million 2020 target materialize, and how much growth depends on new products versus handset shipments.
- Customer concentration, especially major royalty contributors and Spreadtrum, and any changes in customer product plans or reported shipments.
- Progress against the 2022 targets, including the assumptions behind licensing growth, royalty expansion and non-GAAP net income.
- How Hillcrest and Immervision contribute revenue and licensing wins relative to acquisition/investment costs and the forecast increases in R&D and cost of revenue.
- Cash generation, the composition and accessibility of foreign-held liquidity, investment portfolio risks, and potential IIA or tax-related payments.